We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Astellas Pharma stock opened at $9.78 on Thursday. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.10 and a quick ratio of 0.86. The business has a fifty day simple ...

Aaaaaa Aaaaaaa Aaaa 113.80 +22.98% ...

It is an antibody-drug conjugate (ADC) that acts by targeting nectin-4. Astellas Pharma (Astellas) discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company’s ...

ASP-3082 is under clinical development by Astellas Pharma and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase I drugs for Pancreatic Ductal Adenocarcinoma ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Japanese citizen indicted on suspicion of espionage, China confirms Worldcategory· August 22, 2024 Chinese authorities have indicted a Japanese employee of Astellas Pharma Inc detained since ...

A Japanese man detained by Chinese authorities in Beijing earlier this month who may be charged with spying is an employee of Astellas Pharma Inc., a major pharmaceutical company. The Tokyo-based ...